166 related articles for article (PubMed ID: 30057385)
1. Occult cancer and thromboembolism: current epidemiology and its practical implications.
Chao CH; Wang HY; Kao CH
Pol Arch Intern Med; 2018 Sep; 128(9):539-544. PubMed ID: 30057385
[TBL] [Abstract][Full Text] [Related]
2. Venous thromboembolism and occult cancer: impact on clinical practice.
Gheshmy A; Carrier M
Thromb Res; 2016 Apr; 140 Suppl 1():S8-11. PubMed ID: 27067984
[TBL] [Abstract][Full Text] [Related]
3. Limited screening with versus without (18)F-fluorodeoxyglucose PET/CT for occult malignancy in unprovoked venous thromboembolism: an open-label randomised controlled trial.
Robin P; Le Roux PY; Planquette B; Accassat S; Roy PM; Couturaud F; Ghazzar N; Prevot-Bitot N; Couturier O; Delluc A; Sanchez O; Tardy B; Le Gal G; Salaun PY;
Lancet Oncol; 2016 Feb; 17(2):193-199. PubMed ID: 26672686
[TBL] [Abstract][Full Text] [Related]
4. Screening for Occult Cancer in Unprovoked Venous Thromboembolism.
Carrier M; Lazo-Langner A; Shivakumar S; Tagalakis V; Zarychanski R; Solymoss S; Routhier N; Douketis J; Danovitch K; Lee AY; Le Gal G; Wells PS; Corsi DJ; Ramsay T; Coyle D; Chagnon I; Kassam Z; Tao H; Rodger MA;
N Engl J Med; 2015 Aug; 373(8):697-704. PubMed ID: 26095467
[TBL] [Abstract][Full Text] [Related]
5. Risk factors predictive of occult cancer detection in patients with unprovoked venous thromboembolism.
Ihaddadene R; Corsi DJ; Lazo-Langner A; Shivakumar S; Zarychanski R; Tagalakis V; Solymoss S; Routhier N; Douketis J; Le Gal G; Carrier M
Blood; 2016 Apr; 127(16):2035-7. PubMed ID: 26817957
[TBL] [Abstract][Full Text] [Related]
6. Effect of occult cancer screening on mortality in patients with unprovoked venous thromboembolism.
Robin P; Otten HM; Delluc A; van Es N; Carrier M; Salaün PY; Le Gal G
Thromb Res; 2018 Nov; 171():92-96. PubMed ID: 30268858
[TBL] [Abstract][Full Text] [Related]
7. In patients with unprovoked VTE, does the addition of FDG PET/CT to a limited occult cancer screening strategy offer good value for money? A cost-effectiveness analysis from the publicly funded health care systems.
Robin P; Kumar S; Salaun PY; Le Roux PY; Couturaud F; Planquette B; Merah A; Roy PM; Thavorn K; Le Gal G
Thromb Res; 2018 Nov; 171():97-102. PubMed ID: 30268859
[TBL] [Abstract][Full Text] [Related]
8. Screening for Occult Cancer in Patients with Venous Thromboembolism: Past, Present, and Future.
van Es N; Ay C; Jara-Palomares L
Hamostaseologie; 2020 Aug; 40(3):270-279. PubMed ID: 32726822
[TBL] [Abstract][Full Text] [Related]
9. Additional testing following screening strategies for occult malignancy diagnosis in patients with unprovoked venous thromboembolism.
Robin P; Le Roux PY; Le Moigne E; Planquette B; Prévot-Bitot N; Roy PM; Pastre J; Merah A; Couturaud F; Le Gal G; Salaun PY
Thromb Res; 2017 Jul; 155():6-9. PubMed ID: 28460260
[No Abstract] [Full Text] [Related]
10. Revisiting occult cancer screening in patients with unprovoked venous thromboembolism.
Robin P; Carrier M
Thromb Res; 2018 Apr; 164 Suppl 1():S7-S11. PubMed ID: 29703487
[TBL] [Abstract][Full Text] [Related]
11. Screening for Occult Cancer in Patients with Venous Thromboembolism.
D'Astous J; Carrier M
J Clin Med; 2020 Jul; 9(8):. PubMed ID: 32726911
[TBL] [Abstract][Full Text] [Related]
12. A clinical practice-based evaluation of the RIETE score in predicting occult cancer in patients with venous thromboembolism.
Rosell A; Lundström S; Mackman N; Wallén H; Thålin C
J Thromb Thrombolysis; 2019 Jul; 48(1):111-118. PubMed ID: 30739306
[TBL] [Abstract][Full Text] [Related]
13. Screening for occult malignancy with FDG-PET/CT in patients with unprovoked venous thromboembolism.
Alfonso A; Redondo M; Rubio T; Del Olmo B; Rodríguez-Wilhelmi P; García-Velloso MJ; Richter JA; Páramo JA; Lecumberri R
Int J Cancer; 2013 Nov; 133(9):2157-64. PubMed ID: 23616232
[TBL] [Abstract][Full Text] [Related]
14. Positron emission tomography combined with computed tomography as a screening tool for occult malignancy in patients with unprovoked venous thromboembolism: an observational study.
Chauchard M; Benali K; Papo T; Sacre K
Medicine (Baltimore); 2014 Nov; 93(21):e110. PubMed ID: 25380083
[TBL] [Abstract][Full Text] [Related]
15. [Screening for occult cancer in patients with unprovoked venous thromboembolism].
Qiao LS; Xu XM
Zhonghua Jie He He Hu Xi Za Zhi; 2023 May; 46(5):498-502. PubMed ID: 37147813
[TBL] [Abstract][Full Text] [Related]
16. [Screening for cancer in case of venous thromboembolism: when and how?].
Sevestre MA
Rev Prat; 2022 Mar; 72(3):267-269. PubMed ID: 35638947
[TBL] [Abstract][Full Text] [Related]
17. Risk Scores for Occult Cancer in Patients with Venous Thromboembolism: A Post Hoc Analysis of the Hokusai-VTE Study.
Kraaijpoel N; van Es N; Raskob GE; Büller HR; Carrier M; Zhang G; Lin M; Grosso MA; Di Nisio M
Thromb Haemost; 2018 Jul; 118(7):1270-1278. PubMed ID: 29864787
[TBL] [Abstract][Full Text] [Related]
18. Cost effectiveness of the addition of a comprehensive CT scan to the abdomen and pelvis for the detection of cancer after unprovoked venous thromboembolism.
Coyle K; Carrier M; Lazo-Langner A; Shivakumar S; Zarychanski R; Tagalakis V; Solymoss S; Routhier N; Douketis J; Coyle D
Thromb Res; 2017 Mar; 151():67-71. PubMed ID: 28160670
[TBL] [Abstract][Full Text] [Related]
19. Real-world experience with limited screening for occult malignancy in patients presenting with spontaneous venous thromboembolism: a single-centre, retrospective cohort study.
Grainger BT; McCrea TA; Eaddy N; Ockelford P; Young L
Intern Med J; 2022 Mar; 52(3):491-494. PubMed ID: 35307933
[TBL] [Abstract][Full Text] [Related]
20. Performance of
Robin P; van Es N; Le Roux PY; Rondina M; Lecumberri R; Beckers M; Le Gal G; Salaun PY
Thromb Res; 2020 Oct; 194():153-157. PubMed ID: 32788108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]